Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

Apr 22, 2022

SELL
$131.98 - $163.75 $1.04 Million - $1.29 Million
-7,900 Closed
0 $0
Q2 2021

Jul 20, 2021

SELL
$105.21 - $117.21 $1.34 Million - $1.49 Million
-12,700 Reduced 61.65%
7,900 $890,000
Q4 2020

Jan 26, 2021

SELL
$80.49 - $108.67 $1.97 Million - $2.66 Million
-24,500 Reduced 54.32%
20,600 $2.21 Million
Q3 2020

Oct 13, 2020

BUY
$85.91 - $100.83 $3.2 Million - $3.75 Million
37,200 Added 470.89%
45,100 $3.95 Million
Q1 2020

Apr 19, 2021

BUY
$64.5 - $97.79 $509,550 - $772,541
7,900 New
7,900 $0

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Equitec Proprietary Markets, LLC Portfolio

Follow Equitec Proprietary Markets, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Equitec Proprietary Markets, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Equitec Proprietary Markets, LLC with notifications on news.